Article · Journal · 2022

RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION

African Journal of Infectious Diseases

Citations: 4from other works
Field-weighted impact: 1.111.00 is the world average for its field and year
Among its field: 78th percentileby citations, against works of its field and year
Authors: 14from 4 institutions

Authors

14 authors across 4 institutions in 2 countries